- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
Patent holdings for IPC class C12N 15/10
Total number of patents in this class: 16128
10-year publication summary
|
775
|
926
|
1110
|
1435
|
1473
|
1651
|
1710
|
1670
|
1699
|
1077
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| President and Fellows of Harvard College | 5838 |
403 |
| Massachusetts Institute of Technology | 9837 |
378 |
| The Regents of the University of California | 19182 |
364 |
| The Broad Institute, Inc. | 1638 |
334 |
| Illumina, Inc. | 2932 |
300 |
| Qiagen GmbH | 913 |
180 |
| 10X Genomics, Inc. | 1018 |
176 |
| The Board of Trustees of the Leland Stanford Junior University | 6114 |
138 |
| Bio-Rad Laboratories, Inc. | 1602 |
121 |
| The General Hospital Corporation | 4575 |
115 |
| Life Technologies Corporation | 3127 |
113 |
| Twist Bioscience Corporation | 226 |
107 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 301 |
107 |
| Pioneer Hi-Bred International, Inc. | 6313 |
97 |
| University of Vienna | 109 |
85 |
| Illumina Cambridge Limited | 681 |
84 |
| F. Hoffmann-La Roche AG | 7961 |
78 |
| Regeneron Pharmaceuticals, Inc. | 3825 |
78 |
| Becton, Dickinson and Company | 6896 |
71 |
| New England BioLabs, Inc. | 474 |
69 |
| Other owners | 12730 |